Molecular Risk Assessment at Medical Drugs Glossary

What is Molecular Risk Assessment? A procedure in which biomarkers (for example, biological molecules or changes in tumor cell DNA) are used to estimate a persons risk for developing cancer. Specific biomarkers may be linked to particular types of cancer.

Medical Term & Definition Added By: Jenna

Send To Friends!

If you'd like to send the Molecular Risk Assessment definition to yourself or to your friends/colleagues, just enter the e-mail addresses in the boxes below -

We hope you now understand the meaning of Molecular Risk Assessment. If you need any more information on this term, please don't hesitate to contact us.

Other Similar Drugs Terms:

Prescription Drugs Term Cytotoxic T cell is A T-lymphocyte subset that recognizes a specific antigen presented by an MHC Class I molecule, and lyses the cell.

Prescription Drugs Term phase II detoxification is A process in which the liver uses one of two major enzyme pathways to change a toxic substance, such as an anticancer drug, into a less toxic substance that is easier for the body to excrete. In phase II detoxification, liver cells add a substance (such a

Prescription Drugs Term valrubicin is A drug that is used to treat bladder cancer that does not respond to BCG (Bacillus Calmette Guerin). It is an anthracycline and belongs to the family of drugs called antitumor antibiotics. Also called AD 32.

Prescription Drugs Term Cleavage is The splitting up of a complex molecule into two or more simpler molecules. The series of cell divisions occurring in the ovum immediately following its fertilization.

Prescription Drugs Term Biomed 101 is A substance that is being studied for its ability to decrease the side effects of interleukin-2 (IL-2).